158 related articles for article (PubMed ID: 38377402)
1. The dosimetric parameters impact on local recurrence in stereotactic radiotherapy for brain metastases.
Berthet C; Lucia F; Bourbonne V; Schick U; Lecouillard I; Le Deroff C; Barateau A; de Crevoisier R; Castelli J
Br J Radiol; 2024 Mar; 97(1156):820-827. PubMed ID: 38377402
[TBL] [Abstract][Full Text] [Related]
2. Significant correlation between gross tumor volume (GTV) D98% and local control in multifraction stereotactic radiotherapy (MF-SRT) for unresected brain metastases.
Dupic G; Brun L; Molnar I; Leyrat B; Chassin V; Moreau J; Dedieu V; Khalil T; Verrelle P; Lapeyre M; Biau J
Radiother Oncol; 2021 Jan; 154():260-268. PubMed ID: 33245944
[TBL] [Abstract][Full Text] [Related]
3. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
4. Radionecrosis after repeated courses of radiotherapy under stereotactic conditions for brain metastases: Analysis of clinical and dosimetric data from a retrospective cohort of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Cox DG; Bund C; Antoni D; Cebula H; Noel G
Cancer Radiother; 2022 Sep; 26(5):692-702. PubMed ID: 35715354
[TBL] [Abstract][Full Text] [Related]
5. Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors.
Leyrat B; Khalill T; Lemaire JJ; Casile M; Molnar I; Dedieu V; Chassin V; Dupic G; Bellière A; Durando X; Lapeyre M; Verrelle P; Biau J
Clin Transl Radiat Oncol; 2022 Sep; 36():1-8. PubMed ID: 35733828
[TBL] [Abstract][Full Text] [Related]
6. Inhomogeneous tumor dose distribution provides better local control than homogeneous distribution in stereotactic radiotherapy for brain metastases.
Lucia F; Key S; Dissaux G; Goasduff G; Lucia AS; Ollivier L; Pradier O; Schick U
Radiother Oncol; 2019 Jan; 130():132-138. PubMed ID: 30017105
[TBL] [Abstract][Full Text] [Related]
7. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
8. Predictors of local control after robotic stereotactic radiotherapy for brain metastases: 10-years-experience after Cyberknife installation.
Demir H; Doğan B; Günbey HP; Işık N; Yaprak G
ANZ J Surg; 2024 May; 94(5):833-839. PubMed ID: 37984534
[TBL] [Abstract][Full Text] [Related]
9. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.
Andratschke N; Parys A; Stadtfeld S; Wurster S; Huttenlocher S; Imhoff D; Yildirim M; Rades D; Rödel CM; Dunst J; Hildebrandt G; Blanck O
Radiat Oncol; 2016 May; 11():74. PubMed ID: 27236333
[TBL] [Abstract][Full Text] [Related]
10. Choosing a Prescription Isodose in Stereotactic Radiosurgery for Brain Metastases: Implications for Local Control.
Romano KD; Trifiletti DM; Garda A; Xu Z; Schlesinger D; Watkins WT; Neal B; Larner JM; Sheehan JP
World Neurosurg; 2017 Feb; 98():761-767.e1. PubMed ID: 27867125
[TBL] [Abstract][Full Text] [Related]
11. Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy.
Uto M; Ogura K; Katagiri T; Takehana K; Mizowaki T
Radiat Oncol; 2021 Jul; 16(1):140. PubMed ID: 34321033
[TBL] [Abstract][Full Text] [Related]
12. Surgical bed stereotactic radiotherapy of brain metastases: Clinical outcome and predictors of local and distant brain failure.
Mousli A; Bihin B; Gustin T; Koerts G; Mouchamps M; Daisne JF
Cancer Radiother; 2020 Jul; 24(4):298-305. PubMed ID: 32173270
[TBL] [Abstract][Full Text] [Related]
13. Understanding the Effect of Prescription Isodose in Single-Fraction Stereotactic Radiosurgery on Plan Quality and Clinical Outcomes for Solid Brain Metastases.
Brown MH; Marcrom SR; Patel MP; Popple RA; Travis RL; McDonald AM; Riley KO; Markert JM; Willey CD; Bredel M; Fiveash JB; Thomas EM
Neurosurgery; 2023 Dec; 93(6):1313-1318. PubMed ID: 37449861
[TBL] [Abstract][Full Text] [Related]
14. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
15. Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence.
Bishop AJ; Tao R; Rebueno NC; Christensen EN; Allen PK; Wang XA; Amini B; Tannir NM; Tatsui CE; Rhines LD; Li J; Chang EL; Brown PD; Ghia AJ
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1016-1026. PubMed ID: 26025777
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy of adrenal metastases-A dose-finding study.
Buergy D; Würschmidt F; Gkika E; Hörner-Rieber J; Knippen S; Gerum S; Balermpas P; Henkenberens C; Voglhuber T; Kornhuber C; Barczyk S; Röper B; Rashid A; Blanck O; Wittig A; Herold HU; Brunner TB; Sweeney RA; Kahl KH; Ciernik IF; Ottinger A; Izaguirre V; Putz F; König L; Hoffmann M; Combs SE; Guckenberger M; Boda-Heggemann J
Int J Cancer; 2022 Aug; 151(3):412-421. PubMed ID: 35383919
[TBL] [Abstract][Full Text] [Related]
17. Ten-Fraction Stereotactic Radiosurgery With Different Gross Tumor Doses and Inhomogeneities for Brain Metastasis of >10 cc: Treatment Responses Suggesting Suitable Biological Effective Dose Formula for Single and 10 Fractions.
Ohtakara K; Nakabayashi K; Suzuki K
Cureus; 2023 Feb; 15(2):e34636. PubMed ID: 36895545
[TBL] [Abstract][Full Text] [Related]
18. Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial.
Kirkpatrick JP; Wang Z; Sampson JH; McSherry F; Herndon JE; Allen KJ; Duffy E; Hoang JK; Chang Z; Yoo DS; Kelsey CR; Yin FF
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):100-8. PubMed ID: 25442342
[TBL] [Abstract][Full Text] [Related]
19. Impact of adjuvant fractionated stereotactic radiotherapy dose on local control of brain metastases.
Musunuru HB; Witt JS; Yadav P; Francis DM; Kuczmarska-Haas A; Labby ZE; Bassetti MF; Howard SP; Baschnagel AM
J Neurooncol; 2019 Nov; 145(2):385-390. PubMed ID: 31606876
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiation therapy in oligometastatic colorectal cancer: outcome of 102 patients and 150 lesions.
Dell'Acqua V; Surgo A; Kraja F; Kobiela J; Zerella MA; Spychalski P; Gandini S; Francia CM; Ciardo D; Fodor C; Ferrari AM; Piperno G; Cattani F; Vigorito S; Pansini F; Petz W; Orecchia R; Leonardi MC; Jereczek-Fossa BA
Clin Exp Metastasis; 2019 Aug; 36(4):331-342. PubMed ID: 31165360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
